02.26.26 -- Why Dr. Robert Califf Isn't Pulling His Punches Anymore

Bioanalysis must replace manual processes and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.

Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.

Technology alone doesn’t guarantee success. Here, we explain how integrated processes, skilled teams, and collaborative partnerships complement innovation to reduce risk and improve patient outcomes.

Learn how to identify common CRO selection pitfalls and apply expert-backed strategies to protect your clinical program from costly risks and delays.

Quickly address critical formulation issues and optimizing performance. Explore services for small molecules and synthetic peptides across oral, topical, rectal, and parenteral routes.

Leverage our extensive expertise across over 120 therapeutic indications to drive your success.

Centralized submissions, greater transparency, and stronger patient protections reshape EU clinical trials, impacting timelines, costs, and strategies for sponsors and CROs.

Learn how Asian ethnobridging trials in Phase 1 demonstrate PK similarity and help cut years off global drug development timelines.

Explore the rapidly evolving landscape of regulatory processes as they undergo a profound digital transformation, highlighting how emerging technologies are reshaping traditional regulatory frameworks.

The long-awaited ICH E6(R3) guideline is here and will reshape clinical trial standards. Get ahead of the transition with a detailed comparison and strategic insights designed for sponsors and CROs.